Back to Search
Start Over
SARS‐CoV‐2 and influenza viruses: Strategies to cope with coinfection and bioinformatics perspective
- Source :
- Cell Biology International. 46:1009-1020
- Publication Year :
- 2022
- Publisher :
- Wiley, 2022.
-
Abstract
- Almost a century after the devastating pandemic of the Spanish flu, humankind is facing the relatively comparable global outbreak of COVID-19. COVID-19 is an infectious disease caused by SARS-CoV-2 with an unprecedented transmission pattern. In the face of the recent repercussions of COVID-19, many have argued that the clinical experience with influenza through the last century may have tremendous implications in the containment of this newly emerged viral disease. During the last 2 years, from the emergence of COVID-19, tremendous advances have been made in diagnosing and treating coinfections. Several approved vaccines are available now for the primary prevention of COVID-19 and specific treatments exist to alleviate symptoms. The present review article aims to discuss the pathophysiology, diagnosis, and treatment of SARS-CoV-2 and influenza A virus coinfection while delivering a bioinformatics-based insight into this subject matter.
Details
- ISSN :
- 10958355 and 10656995
- Volume :
- 46
- Database :
- OpenAIRE
- Journal :
- Cell Biology International
- Accession number :
- edsair.doi.dedup.....6fd684fdde77c6521edb09576c88b48c